Business Combination, Contingent Consideration, Liability
Amgen Business Combination, Contingent Consideration, Liability increased by 7.5% to $173.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 66.3%, from $104.00M to $173.00M. Over 5 years (FY 2020 to FY 2025), Business Combination, Contingent Consideration, Liability shows an upward trend with a 37.3% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
How to read this metric
An increase suggests the acquired business is meeting or exceeding performance targets, which will require higher future cash payouts.
Detailed definition
This represents the fair value of a liability recognized when the company is obligated to pay additional consideration t...
Peer comparison
This is a standard liability for companies pursuing aggressive M&A strategies with performance-based earn-out structures.
other_business_combination_contingent_consideration_liabilityHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $48.00M | $35.00M | $342.00M | $330.00M | $310.00M | $302.00M | $270.00M | $273.00M | $248.00M | $98.00M | $96.00M | $96.00M | $107.00M | $112.00M | $106.00M | $104.00M | $90.00M | $95.00M | $161.00M | $173.00M |
| QoQ Change | — | -27.1% | +877.1% | -3.5% | -6.1% | -2.6% | -10.6% | +1.1% | -9.2% | -60.5% | -2.0% | +0.0% | +11.5% | +4.7% | -5.4% | -1.9% | -13.5% | +5.6% | +69.5% | +7.5% |
| YoY Change | — | — | — | — | +545.8% | +762.9% | -21.1% | -17.3% | -20.0% | -67.5% | -64.4% | -64.8% | -56.9% | +14.3% | +10.4% | +8.3% | -15.9% | -15.2% | +51.9% | +66.3% |
Business Combination, Contingent Consideration, Liability at Other Companies
Frequently Asked Questions
- What is Amgen's business combination, contingent consideration, liability?
- Amgen (AMGN) reported business combination, contingent consideration, liability of $173.00M in Q1 2026.
- How has Amgen's business combination, contingent consideration, liability changed year-over-year?
- Amgen's business combination, contingent consideration, liability increased by 66.3% year-over-year, from $104.00M to $173.00M.
- What is the long-term trend for Amgen's business combination, contingent consideration, liability?
- Over 5 years (2020 to 2025), Amgen's business combination, contingent consideration, liability has grown at a 37.3% compound annual growth rate (CAGR), from $33.00M to $161.00M.
- What does business combination, contingent consideration, liability mean?
- The estimated amount the company expects to pay in the future based on the performance of an acquired business.